指南与共识哮喘慢阻肺

美国胸科学会/美国国立心肺血液研究所哮喘-慢阻肺重叠研讨会报告

American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.
指南 / 共识 · Am J Respir Crit Care Med · 2017-01-01

哮喘和慢阻肺是高度流行的慢性阻塞性肺疾病,疾病负担高。哮喘常为过敏性,多于婴幼儿或儿童期起病,表现为可变气流阻塞和间歇性喘息、咳嗽、呼吸困难;慢阻肺患者通常为现吸烟或既往吸烟者,40岁后起病,症状常持续,包括呼吸困难和咳痰。基于年龄和吸烟史常易区分,但部分患者兼具两病特征。因临床研究常排除此类患者,其机制和治疗多不确定。为探讨研究现状和机会,NHLBI与ATS于2016年5月14日在旧金山召开研讨会,汇集临床医生、病理学家、放射学家、流行病学家及哮喘和慢阻肺专家,讨论当前认识、知识缺口及研究策略和优先方向,本报告总结这些讨论。

要点

  • 哮喘常儿童期起病、过敏性、可变气流阻塞;慢阻肺多40岁后起病、吸烟相关、症状持续。
  • 部分患者兼具哮喘和慢阻肺特征,临床研究常排除,机制和治疗不确定。
  • 研讨会识别知识缺口并确定研究策略和优先方向以推进ACO理解。

核心结论

  • 哮喘-慢阻肺重叠患者的疾病机制和治疗 largely uncertain,需深入研究。

研究设计与样本

  • NHLBI与ATS于2016年5月14日在旧金山召开研讨会,汇集多学科专家讨论ACO。

主要发现

  • 哮喘常婴幼儿或儿童期起病,过敏性起源,可变气流阻塞和间歇症状。
  • 慢阻肺患者通常现吸烟或既往吸烟,40岁后起病,症状常持续包括呼吸困难和咳痰。
  • 基于年龄和吸烟史常易区分,但部分患者兼具两病特征,临床研究常排除。

局限性

  • ACO患者常被临床研究排除, underlying disease mechanisms and appropriate treatment remain largely uncertain。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent chronic obstructive lung diseases with an associated high burden of disease. Asthma, which is often allergic in origin, frequently begins in infancy or childhood with variable airflow obstruction and intermittent wheezing, cough, and dyspnea. Patients with COPD, in contrast, are usually current or former smokers who present after the age of 40 years with symptoms (often persistent) including dyspnea and a productive cough. On the basis of age and smoking history, it is often easy to distinguish between asthma and COPD. However, some patients have features compatible with both diseases. Because clinical studies typically exclude these patients, their underlying disease mechanisms and appropriate treatment remain largely uncertain. To explore the status of and opportunities for research in this area, the NHLBI, in partnership with the American Thoracic Society, convened a workshop of investigators in San Francisco, California on May 14, 2016. At the workshop, current understanding of asthma-COPD overlap was discussed among clinicians, pathologists, radiologists, epidemiologists, and investigators with expertise in asthma and COPD. They considered knowledge gaps in our understanding of asthma-COPD overlap and identified strategies and research priorities that will advance its understanding. This report summarizes those discussions.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Woodruff PG, van den Berge M, Boucher RC, et al. American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report. Am J Respir Crit Care Med. 2017. PMID: 28636425. doi:10.1164/rccm.201705-0973WS

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。